Literature DB >> 1931962

An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure.

R G Spencer1, K J Halverson, M Auger, A E McDermott, R G Griffin, P T Lansbury.   

Abstract

The formation of insoluble proteinaceous deposits is characteristic of many diseases which are collectively known as amyloidosis. There is very little molecular-level structural information available regarding the amyloid deposits due to the fact that the constituent proteins are insoluble and noncrystalline. Therefore, traditional protein structure determination methods such as solution NMR and X-ray crystallography are not applicable. We report herein the application of the solid-state NMR technique rotational resonance (R2) to the accurate measurement of carbon-to-carbon distances in the amyloid formed from a synthetic fragment (H2N-LeuMetValGlyGlyValValIleAla-CO2H) of the amyloid-forming protein of Alzheimer's disease (AD). This sequence has been implicated in the initiation of amyloid formation. Two distances measured by R2 indicate that an unusual structure, probably involving a cis amide bond, is present in the aggregated peptide amyloid. This structure is incompatible with the accepted models of fibril structure. A relationship between this structure and the stability of the amyloid is proposed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931962     DOI: 10.1021/bi00107a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Freezing of a fish antifreeze protein results in amyloid fibril formation.

Authors:  Steffen P Graether; Carolyn M Slupsky; Brian D Sykes
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

Review 2.  Solid-state NMR as a probe of amyloid structure.

Authors:  Robert Tycko
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

Review 3.  Protein inheritance (prions) based on parallel in-register beta-sheet amyloid structures.

Authors:  Reed B Wickner; Frank Shewmaker; Dmitry Kryndushkin; Herman K Edskes
Journal:  Bioessays       Date:  2008-10       Impact factor: 4.345

Review 4.  Understanding amyloid fibril formation using protein fragments: structural investigations via vibrational spectroscopy and solid-state NMR.

Authors:  Benjamin Martial; Thierry Lefèvre; Michèle Auger
Journal:  Biophys Rev       Date:  2018-05-31

5.  The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy.

Authors:  W B Stine; S W Snyder; U S Ladror; W S Wade; M F Miller; T J Perun; T F Holzman; G A Krafft
Journal:  J Protein Chem       Date:  1996-02

6.  Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study.

Authors:  P Gao
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

Review 7.  The toxicity in vitro of beta-amyloid protein.

Authors:  L L Iversen; R J Mortishire-Smith; S J Pollack; M S Shearman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

8.  A kinetic model for amyloid formation in the prion diseases: importance of seeding.

Authors:  J H Come; P E Fraser; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.

Authors:  S W Snyder; U S Ladror; W S Wade; G T Wang; L W Barrett; E D Matayoshi; H J Huffaker; G A Krafft; T F Holzman
Journal:  Biophys J       Date:  1994-09       Impact factor: 4.033

Review 10.  The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway.

Authors:  Axel Abelein; Jan Pieter Abrahams; Jens Danielsson; Astrid Gräslund; Jüri Jarvet; Jinghui Luo; Ann Tiiman; Sebastian K T S Wärmländer
Journal:  J Biol Inorg Chem       Date:  2014-04-16       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.